News |

Medtech Accelerator boosts local company developing self-monitoring device for chemotherapy patients

Medtech Accelerator, a joint venture between innovation hub Health Enterprise East (HEE), Eastern AHSN (Academic Health Science Network) and regional business partners to support medtech pioneers, has announced an award of £125,000 to Cambridge-based company NeutroCheck, to progress development of an at-home safety monitoring test for chemotherapy patients.

Life-saving upper GI therapy device is licensed to Medovate for market launch

A pioneering endoscopic surgical device, backed by the Medtech Accelerator, has been licensed to medical device company Medovate who will be responsible for bringing it to market. The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life threatening infection following a leak from the upper gastrointestinal (GI) tract whilst significantly enhancing current treatment methods.

endoluminal vacuum (E-vac) device project Medium

Medtech Accelerator awards £150k to ground-breaking innovations.

The Medtech Accelerator has announced awards totalling £150,000 to support two new clinically-led teams in the fields of critical care logistics and cornea graft replacement surgery.

MedTechBOOST – your innovation gateway into the NHS

This September, the week long MedTechBoost will blend PhD & Post-Doc students and startups, combined with key people at EAHSN, and take them through a structured process of practical ideation, venture development, and lean solution-design, to create and develop ground-breaking new solutions for the NHS.

Medtech Accelerator injects £430k into pioneering, early stage technologies

The Medtech Accelerator is pleased to announce awards amounting to more than £430,000 to four new pioneering projects.

1st Medtech Accelerator Webinar Now Available!

Have an idea to improve clinical practice - such as a device, software and eHealth - find out how the Medtech Accelerator can support your innovation by taking a look at our first webinar which took place on the 11th September.

NVM Private Equity leads investment in Ablatus Therapeutics

NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics (“Ablatus”) alongside existing angel investors and the Medtech Accelerator.

Details of the Latest Medtech Accelerator Health Hack Announced

Medtech Accelerator are pleased to announce details of the latest Health Hack - Patient Safety. Taking place on Thursday 3rd & Friday 4th May 2018 at the Anglia Ruskin University Campus, Chelmsford, we are keen to build on the success of previous Hackathons.

Medtech Accelerator’s funding for NHS innovations hits £670k

Accelerator also receives new £500k investment from Essex County Council...

Medtech Accelerator awards £500k to ground-breaking medical technology projects

Medtech Accelerator, a joint venture with innovation hub Health Enterprise East (HEE), has unveiled its latest round of successfully funded projects, with financial awards totalling nearly half a million pounds.

Details of next Medtech Accelerator Health Hack Announced

Supported by Marks & Clerk LLP and Jaltek Systems, Medtech Accelerator are pleased to announce details of the next Health Hack - Surgery. Taking place on Thursday 18th & Friday 19th January 2018 at the Cambridge Science Park we are keen to build on the success of the first Hackathon - Rehabilitation Technology.

Inaugural Health Hack Seen as a Great Success

Uncovering the latest innovative healthcare technology with the first Medtech Accelerator Health Hack.

Inaugural Health Hack Seen as a Great Success

Boost for NHS Innovation as Medtech Accelerator Announce First Award Winners

The Medtech Accelerator, a new company set up to provide proof of concept financial awards to support development of medical technology and software innovations originating primarily from within the NHS, today announced the first round of successful projects. Three pioneering projects will share in £200K to help progress their early stage technologies towards viable solutions to currently unmet healthcare needs.